Sunitinib as first-line treatment for metastatic renal cell carcinoma (MRCC): Updated results and analysis of prognostic factors from a phase III randomised trial Meeting Abstract
| Authors: | Oudard, S.; Motzer, R. J.; Michaelson, M. D.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixie, O.; Negrier, S.; Kim, S. T.; Chen, J.; Figlin, R. A. |
| Abstract Title: | Sunitinib as first-line treatment for metastatic renal cell carcinoma (MRCC): Updated results and analysis of prognostic factors from a phase III randomised trial |
| Meeting Title: | 23rd Annual Congress of the European Association of Urology |
| Journal Title: | European Urology, Supplements |
| Volume: | 7 |
| Issue: | 3 |
| Meeting Dates: | 2008 Mar 26-29 |
| Meeting Location: | Milan, Italy |
| ISSN: | 1569-9056 |
| Publisher: | European Association of Urology |
| Date Published: | 2008-03-01 |
| Start Page: | 245 |
| Language: | English |
| ACCESSION: | WOS:000253839801100 |
| DOI: | 10.1016/s1569-9056(08)60696-x |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 698 - "Source: Wos" |
